Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PeptiDream | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥301.67B | 20.1x | 0.05 | JP¥2,327.50 | 17% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.8% Upside | Upgrade to Pro+ | |
GNI | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥168.27B | 23.3x | 0.07 | JP¥3,355 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.8% Upside | Upgrade to Pro+ | |
Takara Bio | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥110.18B | -2,118.9x | 20.51 | JP¥915 | -11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sanbio Company | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥73.13B | -23.8x | -0.49 | JP¥1,031 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3% Downside | Upgrade to Pro+ | |
Shin Nippon Biomed Lab | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥67.24B | 13.7x | -1.33 | JP¥1,615 | -6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Heartseed | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥39.25B | -33.3x | -0.9 | JP¥1,766 | 6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Healios K K | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥33.24B | -4.5x | 0.12 | JP¥338 | 8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.3% Downside | Upgrade to Pro+ | |
Pharma Foods | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥26.67B | 8.2x | -0.23 | JP¥951 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chordia Therapeutics | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥18.14B | -9.6x | 0.01 | JP¥266 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
3-D Matrix | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥16.96B | -15.4x | -0.27 | JP¥168 | 7.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AnGes | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥15.56B | -1.2x | -0.14 | JP¥55 | -6.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MediciNova | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥14.72B | -9.4x | 1.45 | JP¥303 | 6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chiome Bioscience | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥14.13B | -7.4x | 0.64 | JP¥211 | -16.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tsubota Laboratory | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥10.97B | 28.6x | 0.2 | JP¥429 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PRISM BioLab | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥10.64B | JP¥296 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
TMS | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥10.57B | -7.4x | 0.2 | JP¥262 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NanoCarrier | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥10.45B | -12.5x | -1.4 | JP¥148 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medinet | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥9.79B | -1.3x | JP¥37 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Linical Co Ltd | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥8.02B | -66.1x | 0.57 | JP¥355 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.8% Upside | Upgrade to Pro+ | |
OncoTherapy | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥7.88B | -7.1x | -0.27 | JP¥29 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NoileImmune Biotech | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥7.88B | -7x | -0.35 | JP¥182 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DNA Chip Research | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥7.4B | -208.2x | -2.39 | JP¥1,093 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cyfuse Biomedical KK | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥7.18B | -5.3x | -1.19 | JP¥910 | 11.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Modalis | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥6.94B | -2x | -0.07 | JP¥100 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carna Biosciences | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.84B | -2.6x | 0.03 | JP¥306 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Veritas In Silico | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.61B | -34.3x | JP¥881 | 8.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kringle | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.51B | -6.8x | -0.29 | JP¥809 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
D.Western Therapeutics Institute | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.49B | -3.6x | 0.1 | JP¥132 | -7.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Funpep | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥4.89B | -4.9x | -0.29 | JP¥151 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kidswell Bio | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥4.59B | -6.5x | JP¥113 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Ribomic | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥4.05B | -4.1x | -0.49 | JP¥97 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BrightPath Biotherapeutics | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥3.94B | -1x | JP¥45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Human Metabolome Tech | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥3.92B | 16.1x | -2.29 | JP¥662 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PhoenixBio Co | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥1.41B | -11x | 0.06 | JP¥347 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |